Cerebrospinal fluid from MS patients shows elevated expression of multiple m6A regulators (e.g., METTL3, METTL14, ALKBH5), though methylation levels are notably decreased in progressive MS compared to relapsing-remitting forms [65]. The gene discussed is METTL3; the disease is myeloid sarcoma.